IHL News: Incannex Expands Intellectual Property Position over IHL-42X - 7th Dec 2022, 12:00am

annb0t

Top 20
Incannex Healthcare

SYDNEY, Australia, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a pharmaceutical company developing proprietary medicinal cannabinoid products and psychedelic medicine therapies for unmet medical needs, is pleased to announce the filing of a provisional patent application directed to the use of IHL-42X for the treatment of Obstructive Sleep Apnoea (‘OSA’).

With this lates...

>>> Read more: Incannex Expands Intellectual Property Position over IHL-42X
 
Top Bottom